Six reads on India’s consumer economy this morning — the money quietly leaving brands for the factories behind them, and a bank punished for telling the truth.
The most-wanted IPO this week makes parts nobody notices
Indo-MIM opened its ₹3,811 crore IPO today at ₹461–485 a share, already trading about 40% above the band in the grey market. The Bengaluru company sells nothing you can name — it uses metal-injection moulding to make precision parts for cars, aircraft and medical devices. For two years India’s consumer listings were about brands; this one is a bet on the supplier behind them, on the China-plus-one shift that pays factories, not shoppers. When investors pay growth multiples for moulds over brands, it says something about how much more they expect you to spend. (Business Standard)
Bandhan’s profit rose 35% and the stock still fell 17%
Bandhan Bank reported first-quarter net profit of ₹502 crore on Wednesday, up 35% — and the stock closed nearly 17% lower. The market ignored the profit and read the guidance: management cut its return-on-assets target by 40 basis points. Loans grew just 1% sequentially as the microfinance book, the bank’s old engine, shrank again, even as the retail book jumped 45%. The lesson for the sector is that guidance is now the main event, and the market has no patience for any lender that admits margins are getting harder. (Business Standard)
Bajaj’s best quarter was built abroad, not at home
Bajaj Auto’s first-quarter profit jumped 46% to ₹3,226 crore, on revenue up 65%. The standout was exports — a record 732,000 units, with the biggest gains in Latin America and Africa, and Nigeria roughly tripling. India’s two-wheeler recovery has been real but cautious, so more of the profit is now earned where the rupee buys a cost edge and buyers are less price-sensitive. A rupee earned in Lagos carries a different margin than one from a discount-heavy Indian showroom — and the more exports rise, the less Bajaj depends on the domestic mood. (Business Today)
The ‘clinically proven’ label is about to get harder to print
India’s food regulator is tightening scrutiny of health claims after industry data showed roughly 85% of flagged digital health-benefit ads had to be changed. The claims under the lens are the familiar ones — boosts immunity, clinically proven, supports gut health — now standard across the wellness aisle. It lands awkwardly: the same money flooding into nutrition depends on exactly these claims to justify a premium. Strip the sentence you can’t prove and a ₹300 wellness product can look like a ₹120 grocery one. The rule may quietly hand the shelf back to incumbents who can afford the evidence. (Business Standard)
FMCG’s volumes are recovering just as its costs climb again
The FMCG earnings season began this week, with Nestlé India first, and analysts expect around 12% revenue growth — roughly 7% from volume, the rest from price. The volume number matters: for over a year growth came from raising prices, not selling more, so a 7% read means the shopper is finally buying again. The catch is on costs — palm oil and crude-linked packaging have climbed since the West Asia conflict, and price hikes won’t fully cover them. Companies can defend volume or margin, rarely both; watch which each management chooses over the next fortnight. (Business Standard)
Read today’s full edition → https://theinsightlabs.in/daily/2026-07-23
Seeing a story we should cover? Just hit reply.
— Satyam · The Insight Labs